Skip to main content
SpringerLink
Log in

Headache Features in Children and Adolescents with COVID-19

  • Chapter
  • First Online:
Headache Disorders in Pandemic Conditions

Part of the book series: Headache ((HEAD))

  • 164 Accesses

Abstract

Children with COVID-19 have milder symptoms and are less at risk of hospitalization and potentially fatal complications than adults. While COVID-19 mortality among children is extremely low, pediatric patients with pre-existing health conditions are at a relatively higher risk of death than those without comorbidities. In infants, evidence about COVID-19 outcomes continues to emerge.

The purpose of this chapter is to investigate headache disorders related to COVID-19 in pediatric age, including both changes in the course of pre-existing primary headache and new onset headaches during infection and in other circumstances (vaccination, pandemic, and its social impact). Although these aspects are increasingly being studied in adults, data in pediatric population are still scarce and focus mainly on the prevalence of headaches linked to the infection, thus making further investigation still necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Jackson WM, Price JC, Eisler L, Sun LS, Lee JJ. COVID19 in pediatric patients: a systematic review. J Neurosurg Anesthesiol. 2022.

    Google Scholar 

  2. Christy A. COVID19: a review for the pediatric neurologist. J Child Neurol. 2020.

    Google Scholar 

  3. Kalyanaraman M, Anderson MR. COVID19 in children. Pediatr Clin North Am. 2022.

    Google Scholar 

  4. Mihai CM, Chisnoiu T, Cambrea CS, Frecus CE, Mihai L, Balasa AL, et al. Neurological manifestations found in children with multisystem inflammatory syndrome. Exp Ther Med. 2022.

    Google Scholar 

  5. Blatz AM, Randolph AG. Severe COVID19 and multisystem inflammatory syndrome in children in children and adolescents. Crit Care Clin. 2022.

    Google Scholar 

  6. The Lancet. Understanding long COVID: a modern medical challenge. Lancet. 2021.

    Google Scholar 

  7. Lin JE, Asfour A, Sewell TB, Hooe B, Pryce P, Earley C, et al. Neurological issues in children with COVID19. Neurosci Lett. 2021.

    Google Scholar 

  8. Badal S, Thapa Bajgain K, Badal S, Thapa R, Bajgain BB, Santana MJ. Prevalence, clinical characteristics, and outcomes of pediatric COVID19: a systematic review and meta-analysis. J Clin Virol. 2021.

    Google Scholar 

  9. Nepal G, Shrestha GS, Rehrig JH, Gajurel BP, Ojha R, Agrawal A, et al. Neurological manifestations of COVID19 associated multi-system inflammatory syndrome in children: a systematic review and meta-analysis. J Nepal Health Res Counc. 2021.

    Google Scholar 

  10. Whittaker, E.; Bamford, A.; Kenny, J.; Kaforou, M.; Jones, C.E.; Shah, P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020.

    Google Scholar 

  11. Sandoval F, Julio K, Méndez G, Valderas C, Echeverría AC, Perinetti MJ, et al. Neurologic features associated with SARSCoV-2 infection in children: a case series report. J Child Neurol. 2021.

    Google Scholar 

  12. Zhu L, Wang J, Huang R, Liu L, Zhao H, Wu C, Zhu C. Clinical characteristics of a case series of children with coronavirus disease 2019. Pediatr Pulmonol. 2020;55(6):1430–2. https://doi.org/10.1002/ppul.24767.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Foster CE, Moulton EA, Munoz FM, Hulten KG, Versalovic J, Dunn J, Revell P, Koy TH, Arrington AS, Marquez L, Campbell J. Coronavirus disease 2019 in children cared for at Texas Children’s hospital: initial clinical characteristics and outcomes. J Pediatric Infect Dis Soc. 2020;9(3):373–7. https://doi.org/10.1093/jpids/piaa072.

    Article  CAS  PubMed  Google Scholar 

  14. Mannheim J, Gretsch S, Layden JE, Fricchione MJ. Characteristics of hospitalized pediatric coronavirus disease 2019 cases in Chicago, Illinois, March-April 2020. J Pediatric Infect Dis Soc. 2020;9(5):519–22. https://doi.org/10.1093/jpids/piaa070.

    Article  CAS  PubMed  Google Scholar 

  15. Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020.

    Google Scholar 

  16. Lagunas-Rangel F.A. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID19): a meta-analysis. J Med Virol. 2020.

    Google Scholar 

  17. Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020.

    Google Scholar 

  18. Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID19. Neurol Sci. 2020.

    Google Scholar 

  19. Caronna E, Ballvé A, Llauradó A, et al. Headache: a striking prodro-mal and persistent symptom, predictive of COVID19 clinical evolution. Cephalalgia. 2020.

    Google Scholar 

  20. Karadaş Ö, Öztürk B, Sonkaya AR, Taşdelen B, Özge A, Bolay H. Latent class cluster analysis identified hidden headache phenotypes in COVID19: impact of pulmonary infiltration and IL-6. Neurol Sci. 2021.

    Google Scholar 

  21. Bolay H, Gül A, Baykan B. COVID19 is a real headache! Headache. 2020;60(7):1415–21.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bolay H, Karadas Ö, Oztürk B, et al. HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID19 with headache: a window to the infection-related headache mechanism. J Headache Pain. 2021.

    Google Scholar 

  23. Trigo J, García-Azorín D, Sierra-Mencía Á, et al. Cytokine and interleukin profile in patients with headache and COVID19: a pilot, CASE-control, study on 104 patients. J Headache Pain. 2021.

    Google Scholar 

  24. De Marinis M, Welch KMA. Headache associated with non-cephalic infections: classification and mechanisms. Cephalalgia. 1992.

    Google Scholar 

  25. Sampaio Rocha-Filho PA, Albuquerque PM, Carvalho LCLS, Dandara Pereira Gama M, Magalhães JE. Headache, anosmia, ageusia and other neurological symptoms in COVID19: a cross- sectional study. J Headache Pain. 2022.

    Google Scholar 

  26. Trigo J, García-Azorín D, Planchuelo-Gómez Á, et al. Factors as-sociated with the presence of headache in hospitalized COVID19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain. 2020.

    Google Scholar 

  27. Rocha-Filho PAS, Magalhães JE. Headache associated with COVID19: frequency, characteristics and association with anosmia and ageusia. Cephalalgia. 2020.

    Google Scholar 

  28. Messlinger K, Neuhuber W, May A. Activation of the trigeminal system as a likely target of SARS-CoV- 2 may contribute to anosmia in COVID - 19. Cephalalgia. 2022.

    Google Scholar 

  29. Viana Vasco Aragão MDF, de Carvalho Leal M, Queiroga Cartaxo Filho O, Moreira Fonseca T, Moraes Valença M. Anosmia in COVID19 associated with injury to the olfactory bulbs evident on MRI. Am J Neuroradiol. 2020.

    Google Scholar 

  30. Cosentino G, Todisco M, Hota N, Della Porta G, Morbini P, Tassorelli C, et al. Neuropathological findings from COVID19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur J Neurol 2021.

    Google Scholar 

  31. Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID19. Nat Neurosci. 2021.

    Google Scholar 

  32. Bolay H, Özge A, Uludüz D, Baykan B. Are migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities? Headache. 2020.

    Google Scholar 

  33. Porta-Etessam J, Matías-Guiu JA, González-García N, Gómez Iglesias P, Santos-Bueso E, Arriola-Villalobos P, et al. Spectrum of headaches associated with SARS-CoV-2 infection: study of healthcare professionals. Headache. 2020.

    Google Scholar 

  34. Caronna E, José Gallardo V, Alpuente A, Torres-Ferrus M, Sánchez-Mateo NM, Viguera-Romero J, et al. Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID19 pandemic: present and future implications. Neurologia. 2021.

    Google Scholar 

  35. Fernández-de-las-Peñas C, Gómez-Mayordomo V, Cuadrado ML, Palacios-Ceña D, Florencio LL, Guerrero AL, et al. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: a case-control study. Cephalalgia. 2021.

    Google Scholar 

  36. López JT, García-Azorín D, Planchuelo-Gómez Á, García-Iglesias C, Dueñas-Gutiérrez C, Guerrero ÁL. Phenotypic characterization of acute headache attributed to SARS-CoV-2: an ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020.

    Google Scholar 

  37. Poncet-Megemont L, Paris P, Tronchere A, Salazard JP, Pereira B, Dallel R, et al. High prevalence of headaches during COVID19 infection: a retrospective cohort study. Headache. 2020.

    Google Scholar 

  38. Papetti L, Alaimo Di Loro P, Tarantino S, Grazzi L, Guidetti V, Parisi P, et al. I stay at home with headache. A survey to investigate how the lockdown for COVID19 impacted on headache in Italian children. Cephalalgia. 2020;

    Google Scholar 

  39. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edn. Cephalalgia. 2018. 38(1);1–211. https://doi.org/10.1177/0333102417738202. PMID: 29368949.

  40. Dallavalle G, Pezzotti E, Provenzi L, Toni F, Carpani A, Borgatti R. Migraine symptoms improvement during the COVID19 lockdown in a cohort of children and adolescents. Front Neurol. 2020.

    Google Scholar 

  41. Russo A, Bruno A, Trojsi F, Tessitore A, Tedeschi G. Lifestyle factors and migraine in childhood. Curr Pain Headache Rep. 2016.

    Google Scholar 

  42. Neut D, Fily A, Cuvellier JC, Vallée L. The prevalence of triggers in paediatric migraine: a questionnaire study in 102 children and adolescents. J Headache Pain. 2012.

    Google Scholar 

  43. Solotareff L, Cuvellier JC, Duhamel A, Vallée L, Tich SNT. Trigger factors in childhood migraine: a prospective clinic-based study from North of France. J Child Neurol. 2017.

    Google Scholar 

  44. Chakravarty A, Mukherjee A, Roy D. Trigger factors in childhood migraine: a clinic-based study from eastern India. J Headache Pain. 2009.

    Google Scholar 

  45. Visudtibhan A, Thampratankul L, Khongkhatithum C, Okascharoen C, Siripornpanich V, Chiemchanya S, et al. Migraine in junior high-school students: a prospective 3-academic-year cohort study. Brain Dev. 2010.

    Google Scholar 

  46. Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Kanti Ray B. Neurological and neuropsychiatric impacts of COVID19 pandemic. Can J Neurol Sci. 2021.

    Google Scholar 

  47. Assathiany R, Salinier C, Béchet S, Dolard C, Kochert F, Bocquet A, Levy C. Face masks in young children during the COVID19 pandemic: parents’ and pediatricians’ point of view. Front Pediatr. 2021.

    Google Scholar 

  48. Howard-Jones AR, Bowen AC, Danchin M, Koirala A, Sharma K, Yeoh DK, et al. COVID19 in children: I. Epidemiology, prevention and indirect impacts. J Paediatr Child Health. 2022.

    Google Scholar 

  49. Karvounides D, Marzouk M, Ross AC, VanderPluym JH, Pettet C, Ladak A, et al. The intersection of COVID19, school, and headaches: problems and solutions. Headache. 2021.

    Google Scholar 

  50. Castaldo M, Waliszewska-Prosół M, Koutsokera M, Robotti M, Straburzyński M, Apostolakopoulou L, et al.; European Headache Federation School of Advanced Studies (EHF-SAS). Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain. 2022.

    Google Scholar 

  51. Hause AM, Baggs J, Marquez P, Myers TR, Gee J, Su JR, Zhang B, Thompson D, Shimabukuro TT, Shay DK. COVID19 vaccine safety in children aged 5-11 Years - United States, November 3-December 19, 2021. MMWR Morb Mortal Wkly Rep. 2021.

    Google Scholar 

  52. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 COVID19 vaccine in adolescents. N Engl J Med. 2021.

    Google Scholar 

  53. Ali K, Berman G, Zhou H, Deng W, Faughnan V, Coronado-Voges M, et al.; Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. N Engl J Med. 2021.

    Google Scholar 

  54. Lv M, Luo X, Shen Q, Lei R, Liu X, Liu E, Li Q, Chen Y. Safety, immunogenicity, and efficacy of COVID19 vaccines in children and adolescents: a systematic review. Vaccines (Basel). 2021.

    Google Scholar 

  55. Gentile E, Delussi M, Abagnale C, Caponnetto V, De Cesaris F, et al. Migraine during COVID19: data from second wave pandemic in an Italian Cohort. Brain Sci. 2021.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Developmental Neurology Unit, Neuroscience Department, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

    Giorgia Sforza & Massimiliano Valeriani

  2. Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University Hospital of Rome, Rome, Italy

    Claudia Ruscitto

  3. University Department of Pediatrics, Bambino Gesù Children’s Hospital, IRCCS, Tor Vergata University Hospital of Rome, Rome, Italy

    Giacomo Racioppi

  4. Center for Sensory-Motor Interaction, Aalborg, Denmark

    Massimiliano Valeriani

Authors
  1. Giorgia Sforza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Ruscitto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giacomo Racioppi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimiliano Valeriani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimiliano Valeriani .

Editor information

Editors and Affiliations

  1. Department of Neurology, Mersin University Faculty of Medicine, Mersin, Türkiye

    Aynur Özge

  2. Neurology, Brain 360-Brain Health Center, Istanbul, Türkiye

    Derya Uludüz

  3. Dept of Neurology & Algology, NÖROM, Neuropsychiatry Center, Gazi University, Ankara, Türkiye

    Hayrunnisa Bolay

  4. Department of Neurology, Gülhane Faculty of Medicine, Ankara, Türkiye

    Ömer Karadaş

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sforza, G., Ruscitto, C., Racioppi, G., Valeriani, M. (2023). Headache Features in Children and Adolescents with COVID-19. In: Özge, A., Uludüz, D., Bolay, H., Karadaş, Ö. (eds) Headache Disorders in Pandemic Conditions . Headache. Springer, Cham. https://doi.org/10.1007/978-3-031-26309-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-26309-5_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-26308-8

  • Online ISBN: 978-3-031-26309-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation